Health hazard evaluation report: HETA-80-009-1383, Inland Steel Corporation, East Chicago, Indiana.
Authors
McQuilkin SD; Schloemer JR; Daniels WJ; Singal M
Source
Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, HETA 80-009-1383, 1983 Oct; :1-22
Breathing zone samples were analyzed for benzene (71432), toluene (108883), and xylene (1330207) at the number 2 coke factory, Inland Steel Corporation (SIC-3312), East Chicago, Indiana in June and July 1980. Evaluation was requested by an employee representative to evaluate worker exposure to byproducts of the coke making process. Workers were concerned about respiratory disorders and high blood pressure. Medical questionnaires were administered and blood and urine samples were obtained from 32 coke workers and 9 laboratory employees. Benzene concentrations ranged from 0.35 to 96 parts per million (ppm). The OSHA standard is 10ppm. Toluene and xylene concentrations were below the federal standards. The most common symptoms reported were fatigue, eye irritation, skin burn, nausea, and headache. All 32 coke workers had elevated urinary phenol concentrations, indicative of benzene exposure. Three laboratory workers had increased urine phenol concentrations. Blood tests showed no evidence of occupational liver toxicity. Urinary phenol concentrations were not correlated with symptoms or blood cell abnormalities. The authors conclude that a health hazard from overexposure to benzene exists. Recommendations include periodic industrial and medical monitoring to identify workers and work areas having high benzene concentrations.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.